4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-055664
Chief Executive Officer bought 150,000 shares at $0.92 ($137,970)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collard Craig A Chief Executive Officer | 2023-11-16 | Purchase | +150,000 | $0.92 | $137,970 | 186,496 | D |
| Open-market purchases · 150,000 sh · avg $0.92 · $137,970 | |||||||
Loading xslF345X05/doc4.xml…